Filing Flows › Globus Medical (GMED) › Q1 2026
Globus Medical (GMED) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Globus Medical (GMED) reported revenue of $760M for the first quarter 2026 (Q1 2026), +27% from a year earlier and -8% from the quarter before. Operating margin was 19.8%, net earnings $124M (16.4% of revenue).
Globus Medical, Q1 2026: revenue $760M (+27% year over year), operating margin 19.8%, net earnings $124M, operating cash flow $202M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $760M | -8% | +27% |
| Operating profit | $150M | -11% | +55% |
| Net earnings | $124M | -12% | +65% |
| Operating cash flow | $202M | -19% | +14% |
| Free cash flow | $163M | — | +15% |
What changed
Revenue was $759.9M in Q1 2026, up 27% year over year and down 8% from the previous quarter. Musculoskeletal Solutions was the largest line at 96% of revenue. Musculoskeletal Solutions added $157.1M year over year (up 27%), 97% of the total change.
Operating profit was $150.4M, a 19.8% margin (up 3.6 points year over year). Of the extra revenue versus Q1 2025, 33% reached operating profit, above the 16% margin then. Total costs grew 22% against revenue growth of 27%. The fastest-growing cost line was Other operating costs (+38%). Net earnings were $124.3M, up 65% year over year. The effective tax rate was 20.9%.
Operating cash flow was $202.4M (up 14% year over year), 163% of net earnings. Non-cash charges added back $69.9M of depreciation and amortization and $12.6M of share-based compensation. After purchases of property and equipment ($39.6M), free cash flow as the company reports it was $162.7M.
Questions
What was Globus Medical's revenue in the first quarter 2026?
Globus Medical (GMED) reported revenue of $760M for the first quarter 2026 (Q1 2026), +27% from a year earlier and -8% from the quarter before.
Was Globus Medical profitable in the first quarter 2026?
Operating profit was $150M (19.8% of revenue) and net earnings $124M.
Source: Globus Medical 10-Q on SEC EDGAR.